OMER
USDOmeros Corporation Common Stock
$6.730-0.330 (-4.674%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$7.060
最高
$7.240
最低
$6.710
交易量
1.29M
公司基本面
市值
458.0M
行業
生物科技
國家
United States
交易統計
平均交易量
3.30M
交易所
NGM
貨幣
USD
52週範圍
最低 $2.95當前 $6.730最高 $13.6
相關新聞
Reuters
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.
查看更多
GlobeNewswire
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term
查看更多
